| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 60.39 mm | 60.39 mm | 60.39 mm | 60.39 mm | 60.39 mm | 60.39 mm |
| Cash burn (monthly) | 6.90 mm | 4.58 mm | 8.73 mm | 9.30 mm | 6.90 mm | 8.33 mm |
| Cash used (since last report) | 19.26 mm | 12.78 mm | 24.37 mm | 25.98 mm | 19.26 mm | 23.27 mm |
| Cash remaining | 41.14 mm | 47.62 mm | 36.03 mm | 34.41 mm | 41.14 mm | 37.12 mm |
| Runway (months of cash) | 6.0 | 10.4 | 4.1 | 3.7 | 6.0 | 4.5 |
| 13F holders | Current |
|---|---|
| Total holders | 73 |
| Opened positions | 15 |
| Closed positions | 16 |
| Increased positions | 11 |
| Reduced positions | 15 |
| 13F shares | Current |
|---|---|
| Total value | 39.81 bn |
| Total shares | 29.84 mm |
| Total puts | 1.27 mm |
| Total calls | 208.81 k |
| Total put/call ratio | 6.1 |
| Largest owners | Shares | Value |
|---|---|---|
| Invus Global Management | 3.65 mm | $9.16 mm |
| Bain Capital Life Sciences Investors | 2.75 mm | $5.91 bn |
| Bain Capital Life Sciences Fund II | 2.75 mm | $6.90 mm |
| Siren, L.L.C. | 2.59 mm | $5.56 bn |
| Adage Capital Partners GP, L.L.C. | 2.07 mm | $4.45 bn |
| Samsara BioCapital | 1.79 mm | $3.84 bn |
| Samsara BioCapital | 1.59 mm | $0.00 |
| Point72 Asset Management | 1.47 mm | $3.16 bn |
| Artal International S.C.A. | 1.46 mm | $0.00 |
| Ally Bridge MedAlpha Master Fund | 1.44 mm | $0.00 |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 2 Dec 24 | Simonian Nancy A | Common Stock | Sell | Dispose S | No | No | 0.2702 | 37,070 | 10.02 k | 4,000 |
| 25 Nov 24 | Simonian Nancy A | Common Stock | Sell | Dispose S | No | No | 0.2653 | 134,713 | 35.74 k | 41,070 |
| 19 Nov 24 | Gerald E Quirk | Common Stock | Sell | Dispose S | No | No | 0.2212 | 46,657 | 10.32 k | 0 |
| 18 Nov 24 | Kristin Stephens | Common Stock | Sell | Dispose S | No | No | 0.22 | 36,133 | 7.95 k | 0 |
| 18 Nov 24 | David Roth | Common Stock | Sell | Dispose S | No | No | 0.1969 | 12,099 | 2.38 k | 0 |
